Sessions & Session Chairs
Sessions
A. Tumor Heterogeneity and Chemoresistance
B. Immune Heterogeneity and Immune Evasion
C. Clonal Evolution and Tumor Heterogeneity
D. Immunotherapy: Strategies to Unleash the Anti-Tumor Response
E. Novel Computational Approaches in Tumor Analyses
F. Proteomics and Metabolomics to Dissect Tumor Tissue Heterogeneity
G. Targeting Tumor Microenvironment and TME as Therapeutical Strategy to Hit Cancer
H. Pre-Clinical Models to Study Cancer Heterogeneity: Emerging Technologies
I. Technological Platforms for Tumor and TME Heterogeneity Studies
'%3e%3cpath%20d='M12.6647%2010.9104C12.4176%2010.325%2012.0589%209.7933%2011.6088%209.34485C11.16%208.89511%2010.6283%208.53653%2010.0432%208.28891C10.038%208.28629%2010.0327%208.28498%2010.0275%208.28236C10.8437%207.69282%2011.3743%206.73252%2011.3743%205.64907C11.3743%203.85423%209.92005%202.40002%208.12522%202.40002C6.33038%202.40002%204.87618%203.85423%204.87618%205.64907C4.87618%206.73252%205.40677%207.69282%206.22296%208.28367C6.21772%208.28629%206.21248%208.2876%206.20724%208.29022C5.62031%208.53783%205.09365%208.89287%204.64167%209.34616C4.19192%209.79496%203.83334%2010.3266%203.58573%2010.9117C3.34247%2011.4846%203.21128%2012.0987%203.19925%2012.721C3.1989%2012.735%203.20135%2012.7489%203.20646%2012.7619C3.21157%2012.7749%203.21924%2012.7868%203.22901%2012.7968C3.23877%2012.8068%203.25045%2012.8148%203.26334%2012.8202C3.27623%2012.8256%203.29007%2012.8284%203.30406%2012.8284H4.09012C4.14776%2012.8284%204.19362%2012.7825%204.19493%2012.7262C4.22113%2011.7148%204.62726%2010.7676%205.34519%2010.0497C6.08802%209.30686%207.07452%208.89811%208.12522%208.89811C9.17592%208.89811%2010.1624%209.30686%2010.9052%2010.0497C11.6232%2010.7676%2012.0293%2011.7148%2012.0555%2012.7262C12.0568%2012.7839%2012.1027%2012.8284%2012.1603%2012.8284H12.9464C12.9604%2012.8284%2012.9742%2012.8256%2012.9871%2012.8202C13%2012.8148%2013.0117%2012.8068%2013.0214%2012.7968C13.0312%2012.7868%2013.0389%2012.7749%2013.044%2012.7619C13.0491%2012.7489%2013.0515%2012.735%2013.0512%2012.721C13.0381%2012.0947%2012.9084%2011.4856%2012.6647%2010.9104ZM8.12522%207.90243C7.52388%207.90243%206.95792%207.66793%206.53214%207.24215C6.10636%206.81636%205.87185%206.2504%205.87185%205.64907C5.87185%205.04773%206.10636%204.48177%206.53214%204.05599C6.95792%203.63021%207.52388%203.3957%208.12522%203.3957C8.72655%203.3957%209.29252%203.63021%209.7183%204.05599C10.1441%204.48177%2010.3786%205.04773%2010.3786%205.64907C10.3786%206.2504%2010.1441%206.81636%209.7183%207.24215C9.29252%207.66793%208.72655%207.90243%208.12522%207.90243Z'%20fill='%235D1EE1'/%3e%3c/g%3e%3c/svg%3e)
Institute fo Cancer Research, CRUK, London, UK
Dr. Chiara Gorrini
Institute fo Cancer Research, CRUK, London, UK
Dr. Laura Conti
Dept Molecular Biotechnology and Health Sciences, University of Turin, Italy
Humanitas Research Hospital, Milan, Italy
Dr. Federica Marchesi
Humanitas Research Hospital, Milan, Italy
Dr. Suhendan Ekmekcioglu
Department of Melanoma Medical Oncology, Division of Cancer Medicine, MDACC
Cancer Genomics Laboratory, The francis Crick Institute, UK
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Dr. Peter Van Loo
Cancer Genomics Laboratory, The francis Crick Institute, UK
Dr. Ilse Rooman
Vrije University of Brussel, Belgium
University of Turin
Dept. Molecular Biotechnology and Health Sciences, University of Turin, Italy
Dr. Paola Cappello
Dept. Molecular Biotechnology and Health Sciences, University of Turin, Italy
Dr. Giuseppina Arbore
ISR Hospital, Milan, Italy
Department of Urology, Houston Methodist, Weill Cornell Medical College, New York, NY, USA
Dr. Arvind Rao
Department of Computational Medicine & Bioinformatics, University of Michcigan
Dr. Yvonne M. Saenger
Department of Medicine, Columbia University Irving Medical Center, New York, NY, USA
Department of Biomedical Engineering, University of Michigan, USA
Dr. Deepak Nagrath
Department of Biomedical Engineering, University of Michigan, USA
Dr. Vincenzo Corbo
University of Verona, Italy
IFO Regina Elena Hospital, Rome, Italy
Dr. Paola Nisticò
IFO Regina Elena Hospital, Rome, Italy
Dr. Alberto Bardelli
University of Turin and IFOM, Italy
Columbia University NY, USA
Prof. Cristine Chio
Columbia University NY, USA
Dr. Giulia Adriani
Singapore Immunology Network (SIgN) Agency for Science, Technology and Research. Singapore
Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Department of Leukemia, Division of Cancer Medicine, MDACC
Dr. Jared Burks
Department of Leukemia, Division of Cancer Medicine, MDACC
Dr. Julienne L Carstens
UT MD Anderson Cancer Center, Houston, TX, USA
Dr. Bernd Bodenmiller
Department of Quantitative Biomedicine, University of Zurich